Palagani, V. Et Al. 2014. Combined inhibition of Notch and JAK/STAT is superior to monotherapies and impairs pancreatic cancer progression. CARCINOGENESIS , vol.35, no.4 , 859-866.

Palagani, V., Bozko, P., El Khatib, M., Belahmer, H., Giese, N., Sipos, B., ... MALEK, N. P.(2014). Combined inhibition of Notch and JAK/STAT is superior to monotherapies and impairs pancreatic cancer progression. CARCINOGENESIS , vol.35, no.4, 859-866.

Palagani, Vindhya Et Al. "Combined inhibition of Notch and JAK/STAT is superior to monotherapies and impairs pancreatic cancer progression," CARCINOGENESIS , vol.35, no.4, 859-866, 2014

Palagani, Vindhya Et Al. "Combined inhibition of Notch and JAK/STAT is superior to monotherapies and impairs pancreatic cancer progression." CARCINOGENESIS , vol.35, no.4, pp.859-866, 2014

Palagani, V. Et Al. (2014) . "Combined inhibition of Notch and JAK/STAT is superior to monotherapies and impairs pancreatic cancer progression." CARCINOGENESIS , vol.35, no.4, pp.859-866.

@article{article, author={Vindhya Palagani Et Al. }, title={Combined inhibition of Notch and JAK/STAT is superior to monotherapies and impairs pancreatic cancer progression}, journal={CARCINOGENESIS}, year=2014, pages={859-866} }